David Han
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
-
- Pharmacogenetics and Drug Metabolism 9
-
- Pharmaceutical studies and practices 4
- Co-authors
- Amit V. Desai (5 shared papers)Christopher Lademacher (5 shared papers)Takao Yamazaki (5 shared papers)Donna L. Kowalski (6 shared papers)Shahzad Akhtar (4 shared papers)Robert W. Townsend (4 shared papers)Ronald Goldwater (5 shared papers)Kota Kato (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (3 papers)Clinical and Translational Science (2 papers)Alzheimer s & Dementia (2 papers)Science Translational Medicine (1 paper)Journal of Alzheimer s Disease (1 paper)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
David Han
23 papers receiving 614 citations
Peers
Comparison fields: 5 of 60
- Pharmacology 87
- Infectious Diseases 168
- Transplantation 17
- Physiology 108
- Nephrology 36
Countries citing papers authored by David Han
This map shows the geographic impact of David Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Han more than expected).
Fields of papers citing papers by David Han
This network shows the impact of papers produced by David Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Han. The network helps show where David Han may publish in the future.
Co-authors
The 25 scholars most cited alongside David Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 117 | |
| 2 | 2016 | 76 | |
| 3 | 2016 | 44 | |
| 4 | 2012 | 41 | |
| 5 | 2016 | 39 | |
| 6 | 2017 | 35 | |
| 7 | 2020 | 35 | |
| 8 | 2020 | 35 | |
| 9 | 2024 | 32 | |
| 10 | 2016 | 27 | |
| 11 | 2017 | 26 | |
| 12 | 2019 | 21 | |
| 13 | 2021 | 19 | |
| 14 | 2023 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2022 | 11 | |
| 17 | 2016 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 2012 | 5 |
About David Han
David Han is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Infectious Diseases, Immunology and Nephrology, having authored 25 papers that have together received 635 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Antifungal resistance and susceptibility (4 papers), Pharmaceutical studies and practices (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Alzheimer's disease research and treatments (3 papers), Gout, Hyperuricemia, Uric Acid (2 papers), Cholesterol and Lipid Metabolism (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Pharmacology (87 citations), Infectious Diseases (168 citations), Transplantation (17 citations), Physiology (108 citations) and Nephrology (36 citations). David Han has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Amit V. Desai, Christopher Lademacher, Takao Yamazaki, Donna L. Kowalski, Shahzad Akhtar, Robert W. Townsend, Ronald Goldwater, Kota Kato, Andreas H. Groll and Larry Ereshefsky. Their work appears in journals such as British Journal of Clinical Pharmacology, Clinical and Translational Science, Alzheimer s & Dementia, Science Translational Medicine and Journal of Alzheimer s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.